The anesthetic drug Byfavo can be prescribed at a general hospital.

According to related industries, Hana Pharm's Byfavo (Remimazolam Besylate) passed DC of Big 5 general hospitals, including Seoul National University Hospital and Asan Medical Center, and will also be able to be prescribed it at major advanced general hospitals this month.

Byfavo is a new anesthetic drug released more than 30 years after the approval of the general anesthetic Propofol.

Launched in March, Byfavo secured manufacturing rights and exclusive sales rights from German company Paion in 2013. It has completed phase 3 of clinical trials for 198 subjects that will carry out general anesthesia in South